Replies to post #231099 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

As in last patient completed dosing? I doubt that. Enrollment complete ought to be likely.

I don’t think any of the discussed likely OLE trial reasons and design require the P2 PDD trial to be complete.